SAB BIOTHERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $39.0M | $12.6M |
| FY2021 | — | $38.5M | $33.2M |
| FY2022 | — | $41.3M | $22.4M |
| FY2023 | — | $57.3M | $56.6M |
| FY2024 | — | $26.0M | $8.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $39.0M | $12.6M |
| FY2021 | — | $38.5M | $33.2M |
| FY2022 | — | $41.3M | $22.4M |
| FY2023 | — | $57.3M | $56.6M |
| FY2024 | — | $26.0M | $8.9M |